Pharmaceuticals

NEXT’s current product portfolio caters to cardiovascular, diabetic and gastrointestinal segments. Now that our recently built manufacturing plant is fully operational, we plan to launch many more products belonging to hepatitis, obesity, antibiotics, allergic conditions, antipyretic, analgesics, PPIs, cough syrups, multivitamins and minerals segments in the near future.

Presently, our portfolio includes following products;


 

DOMFLASH

Domflash Plain 10mg

GLINEXT

Glinext MR 60mg

ROSUNEXT

Rosunext 20mg

ESONEXT

Esonext 40mg

TRIKAT MR

Trikat MR 35mg

SITANEXT

Sitanext 50-500mg

AMPER

amper-10-8

ALACEP

Alacep 250mg